FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corporation (FMC) – Form 4 insider activity filed for Director Eduardo E. Cordeiro.
- Transaction date: 17 Jul 2025
- Securities acquired: 237 common shares at $0 through dividend-equivalent rights associated with previously vested RSUs (non-open-market, code A).
- Post-transaction holding: 31,321 common shares held directly.
- No derivative securities reported; no dispositions, sales, or option exercises disclosed.
The filing reflects a routine, low-value increase in ownership—approximately 0.0002 % of FMC’s 126 m shares outstanding—therefore unlikely to be market-moving. However, continued accumulation, even via dividend equivalents, may signal long-term alignment between the director and shareholders.